1919 Investment Counsel’s Allergan Inc AGN Stock Holding History

1919 Investment Counsel’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$34.3M	Sell	192,342 -51,785	-21%	-$8.6M	0.7%	43
2014 Q2	$41.3M	Sell	244,127 -27,066	-10%	-$4.21M	0.84%	34
2014 Q1	$33.7M	Buy	271,193 +37,945	+16%	+$4.62M	0.69%	46
2013 Q4	$25.9M	Buy	233,248 +9,606	+4%	+$918K	0.54%	56
2013 Q3	$20.2M	Buy	223,642 +48,455	+28%	+$4.35M	0.45%	63
2013 Q2	$14.8M	Buy	+175,187	New	+$18.2M	0.35%	67

Other funds holding AGN

PSCM

Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

1919 Investment Counsel's AGN Position: Q3 2014 in Review

1919 Investment Counsel reduced its Allergan Inc (AGN) stake by 21% in Q3 2014, selling an estimated $8.6M and leaving 192,342 shares worth $34.3M. The position accounts for 0.7% of the portfolio, ranked #43.

1919 Investment Counsel first reported a position in AGN in Q2 2013 and has held it in 6 quarters since. The position peaked at $41.3M in Q2 2014. 749 funds tracked by Wall St. Rank hold AGN as of Q3 2014.

1919 Investment Counsel held 192,342 shares of Allergan Inc worth $34.3M as of Q3 2014.
1919 Investment Counsel sold 51,785 Allergan Inc shares in Q3 2014, an estimated $8.6M.
Allergan Inc made up 0.7% of 1919 Investment Counsel's portfolio in Q3 2014, its #43 holding.
1919 Investment Counsel first reported a position in Allergan Inc in Q2 2013 and has held it in 6 quarters since.
1919 Investment Counsel's Allergan Inc position peaked at $41.3M in Q2 2014.
749 funds tracked by Wall St. Rank held Allergan Inc as of Q3 2014.

Based on 1919 Investment Counsel's 13F filing for Q3 2014, filed 14 Nov 2014.